Background: Chronic heart failure is characterized by decreased exercise capacity with early exacerbation of fatigue and dyspnea. Intrinsic skeletal muscle abnormalities can play a role in exercise intolerance. Causal or contributing factors responsible for muscle alterations have not been completely defined. This study evaluated skeletal muscle oxidative stress and NADPH oxidase activity in rats with myocardial infarction (MI) induced heart failure. Methods and Results: Four months after MI, rats were assigned to Sham, MI-C (without treatment), and MI-NAC (treated with N-acetylcysteine) groups. Two months later, echocardiogram showed left ventricular dysfunction in MI-C; NAC attenuated diastolic dysfunction. In soleus muscle, glutathione peroxidase and superoxide dismutase activity was decreased in MI-C and unchanged by NAC. 3-nitrotyrosine was similar in MI-C and Sham, and lower in MI-NAC than MI-C. Total reactive oxygen species (ROS) production was assessed by HPLC analysis of dihydroethidium (DHE) oxidation fluorescent products. The 2-hydroxyethidium (EOH)/DHE ratio did not differ between Sham and MI-C and was higher in MI-NAC. The ethidium/DHE ratio was higher in MI-C than Sham and unchanged by NAC. NADPH oxidase activity was similar in Sham and MI-C and lower in MI-NAC. Gene expression of p47 phox was lower in MI-C than Sham. NAC decreased NOX4 and p22 phox expression. Conclusions: We corroborate the case that oxidative stress is increased in skeletal muscle of heart failure rats and show for the first time that oxidative stress is not related to increased NADPH oxidase activity.
Introduction
Chronic heart failure is characterized by decreased exercise capacity with early exacerbation of symptoms, such as fatigue and dyspnea. Intrinsic skeletal muscle abnormalities have been described in heart failure patients and hypothesized to play a role in exercise intolerance [1] [2] [3] [4] [5] [6] [7] . Skeletal muscle alterations such as atrophy, fibrosis, decreased oxidative capacity, altered myosin distribution, and contractile dysfunction have been well characterized in several experimental and clinical heart failure studies [3, [6] [7] [8] [9] [10] [11] . However, the causal or contributing factors responsible for muscle alterations have not been completely defined.
There is substantial evidence that systemic and myocardial oxidative stress is augmented during heart failure [12, 13] . More recently, increased oxidative stress was also observed in skeletal muscle [14] [15] [16] . Mice with myocardial infarction presented increased lipoperoxidation and reactive oxygen species (ROS) generation, with no changes in antioxidant enzymes activity [15] . In vastus lateralis muscle biopsies of patients with heart failure, Linke at al. [14] observed increased nitrotyrosine concentration and lipoperoxidation associated with reduced antioxidant enzymes gene expression and activity. However, sources of ROS have not been completely defined.
NADPH oxidase (NOX) family is composed of enzymes whose main function is ROS production [17] . For a long time, only phagocytes were considered to produce superoxide by NADPH oxidase activity. However, in the last decade, six homologues of phagocyte NOX2 (gp91 phox ) subunit were described and identified in various tissues [17] . NOX2 and NOX4 are the two NADPH oxidase isoforms expressed in skeletal muscle [18, 19] . These enzymes share the capacity to generate superoxide and other ROS [17] . Although NOX isoforms present similarities, they differ in mode of interaction with the transmembrane protein p22 phox , and the requirement for additional activation factors. In heart failure, Ohta et al. [20] detected increased NADPH oxidase activity in skeletal muscle of infarcted mice; however, they did not evaluate gene expression of NADPH oxidase subunits or H 2 O 2 generation.
To demonstrate the role of oxidative stress in heart failure-associated skeletal muscle alterations it is important to perform functional interference with an antioxidant. Glutathione (L-γ glutamyl-cysteinyl-glycine) is an endogenous tripeptide that plays a fundamental role in cellular defense against oxidative stress [21, 22] . During heart failure, glutathione redox status is altered and its total concentration decreased in cardiac tissue [23] . N-acetylcysteine (NAC) is a molecule with antioxidant properties; it contains a sulfhydryl group and is a source of cysteine to glutathione synthesis. In a recent study, administration of NAC restored total glutathione levels and reduced oxidative stress markers in infarcted rat heart [23] .
In this study we validated the case that oxidative stress is increased in skeletal muscle of HF rats and showed that oxidative stress is not related to increased NADPH oxidase activity.
Material and Methods

Ethics Statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of Botucatu Medical School, Universidade Estadual Paulista, UNESP (Protocol Number: 707). All surgery was performed under anesthesia, and all efforts were made to minimize suffering.
Myocardial infarction (MI) was induced by ligating the anterior descending coronary artery [24] . Four months later, rats were assigned to three groups: Sham, MI-C (MI without treatment), and MI-NAC (MI treated with N-acetylcysteine, 120 mg/kg/day). Six months after surgery, rats were euthanized. At euthanasia, two observers determined whether the clinical and pathologic heart failure features were present or absent. Tachypnea/labored respiration was the clinical finding. Pathologic findings included pleuropericardial effusion, left atrial thrombi, pulmonary congestion (lung weight-to-body weight (BW) ratio >2 standard deviation above sham group mean), and right ventricular hypertrophy (right ventricle weight-to-BW ratio >0.8 mg/g) [24, 25] .
Echocardiographic evaluation
Echocardiogram was performed before and after NAC treatment (Vivid S6, General Electric Medical Systems, Tirat Carmel, Israel) using a 5 to 11.5 MHz electronic transducer, according to a previously described method [26] [27] [28] [29] .
Infarct size
Left ventricle samples were fixed in a 10% buffered formalin solution for 48 h and stained with picrosirius red according to the previously described method [24, 30] . The lengths of the infarcted and viable myocardial for both the endocardial and epicardial circumferences were determined by planimetry. Infarction size was calculated by dividing the sum of endocardial and epicardial infarcted ventricular lengths by the sum of total (infarcted and viable myocardial) endocardial and epicardial ventricular circumferences. The measurements were acquired from midventricular slices (5-6 mm from the apex), under the assumption that the left midventricular slice shows a close linear relation with the sum of the measurements from all heart slices. A compound microscope (Leica DM LS; Nussloch, Germany) attached to a computerized imaging analysis system (Media Cybernetics, Silver Spring, MD, USA) was used to perform the measurements. Rats with small MI size (<30%) were excluded.
Antioxidant enzymes activity and lipid hydroperoxide concentration
Soleus muscle samples (~200 mg) were homogenized in 5 mL of a cold 0.1 M phosphate buffer, pH 7.0. Tissue homogenates were prepared in a motor-driven Teflon-glass Potter-Elvehjem, tissue homogeniser. The homogenate was centrifuged at 10,000 g, for 15 min, 4 °C, and the supernatant was assayed for total protein, lipid hydroperoxide (LOOH), and glutathione peroxidase (GSH-Px, E.C.1.11.1.9), catalase (E.C.1.11.1.6.), and superoxide dismutase (SOD, E.C.1.15.1.1.) activities by spectrophometry [31] . Enzyme activities were analyzed at 25 °C using a microplate reader (μQuant-MQX 200 with Kcjunior software to computer system control, Bio-Tec Instruments, Winooski, Vermont, USA). Spectrophotometric determinations were performed in a Pharmacia Biotech spectrophotometer with temperature-controlled cuvette chamber (UV/ visible Ultrospec 5000 with Swift II applications software to computer system control, 974213, Cambridge, England, UK). All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Glutathione peroxidase was assayed using 0.15 M phosphate buffer (pH 7.0), containing 5 mM EDTA, 0.0084 M NADPH, 4 μg of GSSG-reductase, 1.125 M NaN3 (sodium aside) and 0.15 M GSH in a total volume of 0.3 ml [32] . To assess superoxide dismutase activity (SOD, E.C. 1.15.1.1), we performed a microplate assay based superoxide mediated-nitro blue tetrazolium (NBT) reduction by an aerobic mixture of NADH (reduced nicotinamide adenine dinucleotide) and phenazine methosulfate (PMS). The complete reaction system consisted of 50 mM phosphate buffer (pH 7.4), 0.1 mM EDTA, 50 μM NBT, 78 μM NADH and 3.3 μM PMS [33] . Catalase activity was determined with phosphate buffer (pH 7.0). The assay mixture consisted of 0.019 M hydrogen peroxide and buffer solution in a final volume of 0.3 ml [34] .
Lipid hydroperoxide was measured through hydroperoxide-mediated oxidation of Fe
2+
, with 100 μl of sample and 900 μl of a reaction mixture containing 250 μM FeSO4, 25 mM H2SO4, 100 μM xylenol orange and 4 mM butylated hydroxytoluene (BHT) in 90% (v/v) methanol [35] .
Malondialdehyde serum concentration
Lipid peroxidation was assessed by measuring malondialdehyde (MDA) by high performance liquid chromatography (HPLC), as reported previously [36] . Briefly, 100 μL of serum was treated with butylated hydroxytoluene (BHT 5% in EtOH), followed by protein precipitation using trichloroacetic acid (TCA 10% w/v), at 95°C for 20 min. The sample was cooled in ice and centrifuged for 5 min at 12,000 g. Supernatant (300 μL) was reacted with 650 μL of thiobarbituric acid (TBA 0.4% w/v, in acetate buffer, pH 3.5) and 50 μL of 3,065 M KOH, warmed to 95 °C for 45 min, and cooled on ice for 5 min. Then, the sample was analyzed for MDA-TBA adducts by an HPLC system with a Pecosphere-3 C18 column (83 × 4.6 mm) using a fluorescence detector (Waters 2475), which was set Ex 515 nm and Em 553 nm. The HPLC mobile phase was 20 mM potassium phosphate buffer:acetonitril (80:20, v:v), and the flow rate was set at 0.8 mL/min. The lower limit of detection is 0.2 pmol for the MDA-TBA adduct. MDA was quantified by comparison of integrated peak areas between samples and standard solution under identical chromatographic conditions.
3-Nitrotyrosine concentration measurement
Nitrotyrosine concentration was measured in soleus muscle by enzyme-linked immunosorbent assay (ELISA) using OxiSelect TM Nitrotyrosine ELISA Kit (STA-305, Cell Biolabs, San Diego, CA, USA).
ROS generation
Muscle fragment (~100 mg) was washed in PBS and incubated in a solution containing PBS/DTPA and 150 μM DHE for 25 min at 37 °C in a dark room. Then, muscle fragment was washed in PBS, transferred to liquid nitrogen, and homogenised with mortar and pestle. The homogenate was resuspended in acetonitrile (0.5 ml), sonicated (3 cycles at 8 W for 10 s), and centrifuged (12,000 g for 10 min at 4°C). Supernatant was dried under vacuum (Speed Vac Plus model SC-110A, Thermo Savant) and pellets maintained at -20°C in the dark until analysis. Samples were resuspended in 80 μL deionized water and injected into HPLC system. Total ROS generation was evaluated in soleus muscle by quantification of two dihydroethidium (DHE) oxidation-derived fluorescent compounds, 2-hydroxyethidium (EOH) and ethidium, using HPLC according to a previously described method [37, 38] . EOH is generated when DHE is oxidized by anion superoxide, while ethidium production is associated to heme proteins levels and peroxidase activity. DHEderived products were expressed as ratios of generated EOH and ethidium over consumed DHE (initial DHE concentration minus remaining DHE).
NADPH oxidase activity NADPH oxidase activity was evaluated in membrane-enriched cellular fraction by quantifying DHE oxidation-derived fluorescent compounds, EOH and ethidium by HPLC according to a previously described method [37, 38] .
Soleus muscle was carefully washed in PBS to remove blood. Muscle fragments (~200 mg) were homogenized in 1 mL of ice-cold lysis buffer containing 50 mM Tris (pH 7.4), 100 mM DTPA, 0,1% β-mercaptoethanol, and protease inhibitors. Then, the samples were sonicated (3 cycles of 10 s at 8 Watts) and centrifuged at 1,000 g for 3 min, at 4 °C. The supernatant was transferred to another microtube and centrifuged at 18,000 g for 10 min, at 4 °C. After, the supernatant was transferred to ultracentrifuge tubes and centrifuged at 100.000 g for 45 min, at 4 °C. The supernatant was then discarded and the precipitate (pellet) was resuspended in 100 μL of lysis buffer [38] . Total protein content was quantified by the Bradford method.
Subsequently, 20 µg of membrane-enriched cellular fraction were incubated in phosphate buffer (50 mM, pH 7.4, with 0.1 mM DTPA) containing DHE (50 μM) and NADPH (300 μM), to a final volume of 100 μL, for 30 min, at 37 °C, in the dark. After 40 μL of 10% trichloroacetic acid were added, the samples were icecooled for 10 min at the dark, and centrifuged at 12,000 g for 10 min, at 4 °C. The supernatant was analyzed by HPLC and the fluorescent DHE-derived products were quantified, according to a previously described method [37, 38] .
Membrane-enriched cellular fraction was also submitted to microplate assay with Amplex Red Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
Total RNA was extracted from soleus muscles with TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and treated with DNase I (Invitrogen Life Technologies). One microgram of RNA was reverse transcribed using High Capacity cDNA Reverse Transcription Kit, according to standard methods (Applied Biosystems, Foster City, CA, USA). Aliquots of cDNA were then submitted to real time PCR reaction using customized assay containing sense and antisense primers and Taqman (Applied Biosystems, Foster City, CA, USA) probe specific to each gene: NOX2 (Rn00576710_m1), NOX4 (Rn00585380_m1), p22 phox (Rn00577357_m1), and p47 phox (Rn00586945_m1). The amplification and analysis were performed using Step One Plus™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Expression data were normalized to reference gene expressions: cyclophilin (Rn00690933_m1), and GAPDH (Rn01775763_g1). Reactions were performed in triplicate and expression levels calculated using the CT comparative method (2 -ΔΔCT ) [42] .
Statistical analysis
Data are expressed as mean±standard deviation. Comparisons between groups were performed by one-way ANOVA and Bonferroni post hoc test (comparisons of interest: Sham versus MI-C and MI-C versus MI-NAC). The Student's t-test was used to compare MI size. Significance level was set at 5%.
Results
Experimental groups and anatomical variables
Sham group rats (n=16) did not present any heart failure features. The frequency of heart failure features in MI-C and MI-NAC groups is shown in Table 1 . Anatomical data are presented in Table 2 
Echocardiograph evaluation
Before NAC administration, all echocardiographic variables were similar between MI-C and MI-NAC groups (data not shown). Cardiac structural and left ventricular function variables evaluated at the end of the experiment are shown in Tables 3 and 4 , respectively. Table 1 . Frequency of heart failure features in the infarcted rats Oxidative stress evaluation Antioxidant enzymes activity. GSH-Px and SOD activity was reduced in MI-C than Sham and did not differ between MI-NAC and MI-C (GHS-Px: Sham 214±24; MI-C 183±14; MI-NAC 180±20 nmol/mg protein; p=0.005; SOD: Sham 877±80; MI-C 769±62; MI-NAC 716±51 nmol/g protein; p<0.001; Fig. 1 ). Catalase activity was similar in Sham and MI-C, and lower in MI-NAC than MI-C (Sham 61.1±19.8; MI-C 49.3±20.8; MI-NAC 27.7±9.4 nmol/g protein; p=0.003; Fig. 1) .
Oxidative stress markers. Soleus muscle lipid hydroperoxide concentration did not differ between groups (Sham 248±13; MI-C 261±29; MI-NAC 249±25 nmol/g tissue; p=0.47; Fig.  2A ). The 3-nitrotyrosine muscle concentration was similar between Sham and MI-C, and lower in MI-NAC than MI-C (Sham 2.89±0.80; MI-C 3.33±0.95; MI-NAC 2.1±0.96 nM/mg protein; p=0.039; Fig. 2B ).
Considering systemic oxidative stress marker levels, MDA serum concentration was higher in MI-C than Sham and did not differ between MI-C and MI-NAC (Sham 0.98±0.22; Gene expression NADPH oxidase complex subunit mRNA expressions are presented in Table 5 . NOX2 expression did not differ between groups. NOX4 e p22phox gene expression was similar between Sham and MI-C, and lower in MI-NAC than in MI-C. In addition, p47phox expression was lower in MI-C than in Sham group, and similar between MI-C and MI-NAC groups.
Discussion
In this study we confirmed that oxidative stress is increased in skeletal muscle of heart failure rats and showed that oxidative stress is not related to increased NADPH oxidase activity. Additionally, we assessed for the first time the influence of the antioxidant N-acetylcysteine on oxidative stress markers.
Experimental myocardial infarction models have been widely used for inducing heart failure. However, only rats with moderate to large myocardial infarction develop heart failure [24] . In this study, rats from MI-C and MI-NAC groups had similar infarct sizes, approximately 48%, which is considered large. Heart failure diagnosis was based on observation of clinical and pathologic features [24, 25] and confirmed by the greater right ventricle and lung weights in MI-C than Sham group. N-acetylcysteine did not modify these variables.
Before N-acetylcysteine treatment, echocardiographic analysis showed that MI-C and MI-NAC groups had a similar degree of cardiac injury (data not shown). After two months of treatment, echocardiographic evaluation showed MI-C rats with dilated left cardiac chambers combined with systolic and diastolic left ventricular dysfunction compared to Sham animals. Diastolic dysfunction was severe in MI-C group, with a restrictive pattern characterized by an increased E/A ratio [24] . Late treatment with NAC did not attenuate structural cardiac changes or systolic ventricular dysfunction, but slightly improved diastolic function, as shown by the lower E/A ratio in MI-NAC. Recent studies have shown that NAC administration initiated 24 hours [43] or two months [23] after MI improves fractional shortening and attenuates cardiac remodelling. As treatment in our study was started four months after MI, it is probable that rats had already presented advanced degrees of left cardiac chambers dilation and ventricular systolic dysfunction, preventing a reverse remodelling process.
Concerning to redox status in skeletal muscle, GSH-Px and SOD enzymes activity was reduced in infarcted groups. Decreased antioxidant enzymes activity in skeletal muscle has already been demonstrated in clinical and experimental studies [5, 14] . The deleterious generated by SOD activity generates water and oxygen by catalase. However, GSH-Px activity depends on glutathione concentration. Glutathione can be found in reduced (GSH) or oxidized (GSSG) forms. Its antioxidant property comes from the ability to react with H 2 O 2 and organic peroxides by GSH-Px activity with consequent GSH to GSSG oxidation. NAC treatment reduced catalase activity and did not restore SOD or GSH-Px activity. A recent study showed that NAC administration restores total glutathione levels and reduces H 2 O 2 and lipid hydroperoxide concentrations in left ventricle from infarcted rats [23] . However, no studies evaluating the influence of NAC treatment on skeletal muscle from heart failure rats were found.
We next evaluated NADPH oxidase complex, an important ROS source. The NOX2 catalytic subunit forms a complex with p22 phox which depends on p47 phox and p67 phox cytosolic regulatory subunits linkage being activated [17] . Although we observed reduced p47 phox gene expression in MI-C, it is possible that p47 phox protein levels (not evaluated in this study) were preserved as was NADPH oxidase activity. Conversely, even though NOX4 interacts with transmembrane protein p22
phox , it differs from other isoforms because it is constitutively active and independent of regulatory or activator cytosolic proteins [17] . In this study, gene expression of NOX4 and p22
phox subunits was not altered in MI-C, which is in accordance with the unchanged NADPH oxidase activity. Information on the role of NADPH oxidase in heart failure-associated skeletal myopathy is scarce. We have identified only one study by Ohta et al. [20] , who differently from us, observed increased NADPH oxidase activity in mice skeletal muscle one month after inducing MI. However, as in other studies [44] , the authors analysed NADPH oxidase activity with a chemiluminescent assay using lucigenin which can be reduced by superoxide anion. In our study, we assayed NADPH oxidase activity using DHE, a molecule which is oxidized by superoxide anion. Thus, our results may have diverged from the Ohta et al. [20] due to the different animal model and NADPH oxidase activity analytical technique.
NAC administration decreased NOX4 and p22 phox and did not restore p47 phox gene expression. Additionally, NADPH oxidase activity was lower in MI-NAC than MI-C. NOX2 activity generates superoxide as a primary product, and hydrogen peroxide (H 2 O 2 ) as a secondary product derived from superoxide dismutation [17] . Recent studies have shown that NOX4 can directly produce H 2 O 2 [39] . Therefore, even though NOX2 gene expression was unchanged in our study, the reduced p22 phox gene expression was associated to decreased superoxide production. Conversely, decreased H 2 O 2 generation was also expected because superoxide generation was lower, but this did not occur probably because NAC did not restore SOD activity. Also, reduced NOX4 and p22 phox gene expression might have led to lower H 2 O 2 production, which unexpectedly did not happen. Additional studies evaluating protein levels of NADPH oxidase enzyme subunits are needed to confirm our data on gene expression.
The oxidative stress markers malondialdehyde and nitrotyrosine were also analysed. We observed that NAC acted differentially on MDA and nitrotyrosine. Several proteins have sulfhydryl groups whose oxidation may lead to protein function loss. Glutathione is able to protect and also regenerate these sulfhydryl groups against ROS attack [45] . Regarding lipid peroxidation, direct glutathione action is only slightly efficient as it is found in aqueous cells compartments. Glutathione depends on GSH-Px activity to remove lipoperoxidationderived products [46] . In our study, GSH-Px was not restored by NAC treatment and may have contributed to maintaining the elevated MDA serum concentration.
Total ROS production was evaluated in soleus muscle. We identified a higher ethidium/ DHE ratio in MI-C compared to Sham and no difference between MI-NAC and MI-C. Besides the origin of the ethidium product being not completely clarified, Fernandes et al. [37] suggested that complex pathways, including heme levels and peroxidase activity, may contribute to its formation. However, as we did not analyse these pathways, the association between heme levels and peroxidase activity and ethidium generation is a hypothesis that needs further confirmation. Also, EOH/DHE ratio was not statistically different between Sham and MI-C, but was surprisingly higher in MI-NAC than MI-C. Evidence has shown that increasing glutathione levels through NAC protects against oxidative stress in several diseases, including heart failure. However, recent studies have documented that, contrary to the common belief that NAC functions solely as an antioxidant, excess glutathione from NAC treatment culminates in reductive stress with pro-oxidative consequences in mitochondria and augmented ROS levels [47] , which may have occurred in our experimental model. Although it has been documented in other studies, the NAC-induced ROS elevation should be further investigated in this experimental model, and it can be considered a limitation of the present study. Furthermore, other antioxidant small molecules should be investigated to verify their efficacy on modulating oxidative stress.
Clinical Perspectives
Heart failure-induced skeletal muscle changes are a high prevalent clinical condition, which is associated with important limitation of functional capacity. Nowadays, there is no specific pharmacologic therapy for skeletal muscle alterations. Therefore, identifying physiopathological mechanisms involved in these alterations is important to develop strategies to prevent and treat muscle deterioration. In this study, we showed that oxidative stress is increased in skeletal muscle of heart failure rats, but is not related to increased NADPH oxidase activity. We also showed that the antioxidant N-acetylcysteine acts differentially on oxidative stress markers. The results suggest that N-acetylcysteine can have a role in modulating skeletal muscle oxidative stress during heart failure.
In conclusion, in this study we confirm that oxidative stress is increased in slowtwitch soleus muscle of heart failure rats, despite unchanged NADPH oxidase activity. N-acetylcysteine is partially effective in reducing oxidative stress, as it decreases NADPH oxidase activity and 3-nitrotyrosine levels.
